| | | | | | | | | | | |
| POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | | | | | | | |
|
| | | UNI - EN REPORT No | 132 | / | 2020 |
| | |
| | | | | | | | | | | |
| Date of issue: | 2020-12-03 | | | | | | | | |
| | | | | | | | | |
| Short name of the issuer | | | | | | | |
| SOPHARMA AD | |
| | | | | | | | | | |
| Subject | | | | | | | | | | |
| Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of December 2, 2020. | |
| | | | | | | | |
| Official market - legal basis | | | | | | |
| art. 56. 1. 2 of Act on Public Offering.
| |
| | | | | | | | | |
| Unofficial market - legal basis | | | | | |
| | |
| | | | | | | | | | | |
| Contents of the report: | | | | | | | | |
| Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of December 2, 2020. | |
| | | | | | | | | | |
| Annexes | | | | | | | | | | |
| File | Description | |
| Current_report_insiders_transaction_DIH_132.pdf | Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of December 2, 2020. | |
| | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | SOPHARMA AD | | |
| | (fullname of the issuer) | | |
| | SOPHARMA AD | | Farmaceutyczny (far) | | |
| | (short name of the issuer) | | (sector according to clasification
of the WSE in Warsow) | | |
| | 1220 | | Sofia | | |
| | (post code) | | (city) | | |
| | IlienskoShosse | | 16 | | |
| | (street) | | (number) | | |
| | +359 2 813 42 00 | | +359 2 936 02 86 | | |
| | (phone number) | | | (fax) | | |
| | | | | | |
| | (e-mail) | | | (web site) | | |
| | nd | | | | |
| | (NIP) | | | (REGON) | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | |
|
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |
| Date | Name | Position / Function | Signature | |
| 2020-12-03 | Ognian Donev | Executive Director | | |
| | | | | |